UK Medical Research Regulators Spared the Axe
By Daniel Cressey,
Nature News Blog
| 07. 18. 2013
The future of the UK regulating bodies for human-embryo and human-tissue research has been safeguarded, as the government’s announcement yesterday that the two bodies will continue to exist brings a long-running saga to an end.
Back in 2010 the government said that it would axe the Human Fertilisation and Embryology Authority (HFEA), which regulates research on human embryos and fertility treatment. The Human Tissue Authority (HTA), which regulates other human tissue research and organ donation, was also to be wound up. The proposals were unpopular with many researchers, and
earlier this year the Department of Health announced that instead it would commission an independent review to see whether the two bodies could be merged.
That review —
published yesterday — found that there was “relatively little overlap” in the work of the two regulators and they should continue as separate bodies. This outcome has been
accepted by the government.
There will be some changes for researchers. Regulation of tissue used for developing medicinal products is to be transferred from the HTA to the UK Medicines and Healthcare Products Regulatory...
Related Articles
By Julia Métraux, Mother Jones | 02.10.2026
Why was Jeffrey Epstein obsessed with genes? In the latest tranche of Epstein records and emails made available by the Department of Justice, themes of genes, genetics, and IQ—alongside more explicit threads of white supremacy—keep cropping up, often adjacent to Epstein’s...
By Teddy Rosenbluth, The New York Times | 02.09.2026
Dr. Mehmet Oz has urged Americans to get vaccinated against measles, one of the strongest endorsements of the vaccine yet from a top health official in the Trump administration, which has repeatedly undermined confidence in vaccine safety.
Dr. Oz, the...
By Ava Kofman, The New Yorker | 02.09.2026
1. The Surrogates
In the delicate jargon of the fertility industry, a woman who carries a child for someone else is said to be going on a “journey.” Kayla Elliott began hers in February, 2024, not long after she posted...
By Alex Polyakov, The Conversation | 02.09.2026
Prospective parents are being marketed genetic tests that claim to predict which IVF embryo will grow into the tallest, smartest or healthiest child.
But these tests cannot deliver what they promise. The benefits are likely minimal, while the risks to...